G213-0132 Screening compound: N~3~-ethyl-N~3~-(2-methylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzisoxazole-3-carboxamide

G213-0132 Screening compound: N~3~-ethyl-N~3~-(2-methylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzisoxazole-3-carboxamide
G213-0132 Screening compound: N~3~-ethyl-N~3~-(2-methylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzisoxazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G213-0132
N~3~-ethyl-N~3~-(2-methylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzisoxazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G213-0132

Molecular Formula

C19H18N2O2S (C19 H18 N2 O2 S)

Compound Name

N~3~-ethyl-N~3~-(2-methylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzisoxazole-3-carboxamide

IUPAC name

N-ethyl-N-(2-methylphenyl)-3-oxa-10-thia-4-azatricyclo[7.3.0.0^{26}]dodeca-1(9)2(6)411-tetraene-5-carboxamide

SMILES

CCN(C(c1noc-2c1CCc1c2ccs1)=O)c1c(C)cccc1

InChI

InChI=1S/C19H18N2O2S/c1-3-21(15-7-5-4-6-12(15)2)19(22)17-14-8-9-16-13(10-11-24-16)18(14)23-20-17/h4-7,10-11H,3,8-9H2,1-2H3

InChI Key

OJJQSKWISPSVSM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14986887

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

338.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.560

Distribution Coefficient, logD

4.560

Water Solubility, LogSw

-4.43

Polar Surface Area

38.384

Acid Dissociation Constant (pKa)

20.30

Base Dissociation Constant (pKb)

-2.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

G213-0132 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G213-0132 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G213-0132?
Check Price and Availability of G213-0132, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G213-0132 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G213-0132
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G213-0132
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G213-0132 available by request